Lab
Lillian I Rivera Ocasio
Lillian I Rivera Ocasio was paid $546K by Medicaid between Jan 2018 and Dec 2024, across 35 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 20% of everything it billed.
33Billing provider infoLILLIAN I RIVERA OCASIO
BAYAMON, PR 00959
BAYAMON, PR 00959
33aNPI1285038182assigned 10/21/2014
33bProvider typeClinical Medical Laboratory
28Total paid$546K
24GClaims37,780
24DCodes billed35
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#233 of 777
Median peer was paid$278K
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,865 | $37K | |
| 2019 | 2,934 | $24K | |
| 2020 | 4,068 | $71K | |
| 2021 | 8,034 | $167K | |
| 2022 | 7,598 | $135K | |
| 2023 | 7,411 | $69K | |
| 2024incomplete | 3,870 | $43K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 20% | 2,245 | 1,908 | $109K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 14% | 3,163 | 2,695 | $74K |
| 84443 | Thyroid stimulating hormone (TSH) | 11% | 3,554 | 3,268 | $58K |
| 80061 | Lipid panel | 9.0% | 3,761 | 3,457 | $49K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 8.7% | 1,099 | 990 | $47K |
| 80053 | Comprehensive metabolic panel | 7.9% | 4,185 | 3,816 | $43K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.8% | 5,623 | 5,021 | $43K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.4% | 2,536 | 2,356 | $24K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.7% | 740 | 688 | $20K |
| 81000 | 2.6% | 4,630 | 4,212 | $14K | |
| 82274 | 2.6% | 906 | 854 | $14K | |
| 86328 | 1.7% | 536 | 485 | $9K |
23 more codes
| 84436 | <1% | 786 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 596 | $4K |
| 87088 | <1% | 512 | $4K | |
| 82043 | <1% | 667 | $4K | |
| 82607 | <1% | 248 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 234 | $3K |
| 86701 | <1% | 271 | $2K | |
| 84153 | <1% | 146 | $2K | |
| 84479 | <1% | 400 | $2K | |
| 84439 | <1% | 241 | $2K | |
| 86738 | <1% | 110 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 42 | $1K |
| 86592 | <1% | 263 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 31 | $994.24 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 29 | $917.76 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 104 | $732.31 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 16 | $341.12 |
| 84702 | <1% | 13 | $213.33 | |
| 82746 | <1% | 14 | $192.24 | |
| 82570 | <1% | 36 | $135.36 | |
| 83540 | <1% | 13 | $84.72 | |
| 84550 | <1% | 16 | $67.68 | |
| 85651 | <1% | 14 | $50.09 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRIVERA OCASIO, LILLIAN (ADMINISTRATOR)